Cost-Utility Analysis of Sofosbuvir for Treatment of Genotype2 Chronic Hepatitis C in Japan

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.827
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Sofosbuvir-Based Treatments for Chronic Hepatitis C in the US

BMC Gastroenterology
MedicineGastroenterology
2015English

Ledipasvir / Sofosbuvir for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pin19 - A Cost Comparison of Treating Chronic Hepatitis C Patients With Sofosbuvir-Based Regimens

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Sofosbuvir Plus Ribavirin in Patients With Genotype 2 Chronic Hepatitis C: An Analysis With Real World Outcomes From a Multicentre Cohort in Japan

BMJ Open
Medicine
2019English

Cost-Effectiveness Analysis of Antiviral Pharmacotherapies for Treatment of Chronic Hepatitis C Virus Infection in Russia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients

PLoS ONE
Multidisciplinary
2011English

Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia

American Journal of Hematology
Hematology
2018English

The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy